Rubicon Organics Reports Q2 2025 Financial and Operating Results

About this update from Rubicon Organics, Inc.

[{"type":"text","content":"Rubicon Organics Reports Q2 2025 Financial and Operating Results\n\n\n\n\n\n Delivered Q2 2025 net revenue of $15.0 million,\n \n representing a\n \n 24% increase\n \n compared to the same quarter in prior year, and\n \n 2025 YTD net revenue of $27.4 million,\n \n representing a\n \n 30% increase\n \n compared to the same six months in prior year\n \n\n Generated\n \n Adjusted EBITDA\n \n\n\n 1\n \n\n\n of $1.4 million in Q2 2025 and $2.1 million for 2025 YTD\n \n\n\n\n Completed purchase\n \n of the\n \n Hope Facility,\n \n increasing total future capacity by 40%\n \n\n\n Completed\n \n a\n \n private placement\n \n for aggregate gross proceeds\n \n of $4.5 million\n \n\n\n\n 1964\n \n Launched Premium\n \n All-in-One Resin Vapes, Expands Into New Segment\n \n\n (July 2025)\n \n\n\n\n\n\n VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”) is Canada’s leading premium licensed producer focused on cultivating and selling organic certified, premium and super-premium cannabis products, reported its financial results for the three and six months ended June 30, 2025 (“Q2 2025”). All amounts are expressed in Canadian dollars.\n \n\n “Our strong results reflect our relentless focus on quality across every aspect of our business. We’re now seeing the established success of our 510-thread FSE resin vapes, which have been in market for a full year, alongside momentum from our premium genetics—underscoring the strength of our genetic strategy. Looking ahead, I’m excited about the potential of our newly launched all-in-one FSE resin vapes, upcoming genetic releases, and the commissioning of our Hope Facility to support continued, sustainable growth.” said Margaret Brodie, CEO.\n \n\n “We delivered a record-breaking quarter, achieving our highest-ever net revenue of $15.0 million, record gross profit, and a record profit from operations of $1.0 million. We also generated Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million. Our strong and consistent performance in the first half of the year reflects the strength of our operating model and our commitment to financial discipline. While we expect some one-time costs in the back ha...

More updates from Rubicon Organics, Inc.